Viewing Study NCT04000295


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-27 @ 9:40 PM
Study NCT ID: NCT04000295
Status: UNKNOWN
Last Update Posted: 2019-10-08
First Post: 2019-06-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module